Vienna, Austria

ESTRO 2023

Session Item

Sunday
May 14
16:45 - 17:45
Lehar 4
Normal tissue radiobiology
Khaled Elsayad, Germany;
Ludwig Dubois, The Netherlands
Proffered Papers
Radiobiology
17:05 - 17:15
Gut Microbiota is Predictive of Radio-induced Gastrointestinal Toxicity in Prostate Cancer Patients
Jacopo Iacovacci, Italy
OC-0597

Abstract

Gut Microbiota is Predictive of Radio-induced Gastrointestinal Toxicity in Prostate Cancer Patients
Authors:

JACOPO IACOVACCI1, Tiziana Rancati1, Eliana Gioscio1, Loris De Cecco2, Barbara Avuzzi3, Barbara Noris Chiorda3, Fabio Badenchini1, Tommaso Giandini4, Alessandro Cicchetti1, Nadia Zaffaroni5, Valentina Doldi5, Elisa Mancinelli6, Mara Serena Serafini2, Andrea Devecchi6, Laura Andreoli3, Ester Orlandi7, Riccardo Valdagni1,8,3

1Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Prostate Cancer Program, Milan, Italy; 2Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Experimental Oncology Department, Milan, Italy; 3Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Division of Radiation Oncology, Milan, Italy; 4Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Division of Medical Physics, Milan, Italy; 5Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Division of Molecular Pharmacology, Milan, Italy; 6Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Applied Research and Technology Development, Milan, Italy; 7National Center for Oncological Hadrontherapy, Radiation Oncology, Milan, Italy; 8Università degli Studi di Milano, Department of Oncology and Hemato-oncology, Milan, Italy

Show Affiliations
Purpose or Objective

The search for factors beyond radiation dose that could improve the identification of prostate cancer patients (PCa) more at risk of toxicity is of extreme interest for personalized RT aiming at ameliorating quality-of-life of all survivors.
To investigate the role that the intestinal microbiota (MB) might play in the development of RT-induced toxicity in the bowel, the MicroLearner study collected faecal samples from 136 (discovery) and 79 (validation) consecutive PCa pts treated with conventional (78Gy @2Gy/fr) or hypofractionated (65Gy @2.6Gy/fr) VMAT+IGRT in 5 fr/week before and after RT.

Material and Methods

Gastrointestinal (GI) toxicity was assessed weakly during RT using CTCAE. Average grade > 1.3 over time points was used to identify a group of 16/136 (discovery) and 8/79 (validation) pts that suffered from acute form of GI toxicity. Operational Taxonomic Units abundances were extracted using 16S rRNA amplicon sequencing and Metagenomic 16S Thermo Fisher bioinformatics pipeline. A core MB at the genus level was extracted in the discovery cohort by selecting taxa found with a relative abundance greater or equal to 2% in at least 10% of the samples. Using the core MB, we developed a clinical decision-tree that evaluates the relative abundance of specific genera and tested its ability to predict the risk of toxicity both in internal and external (MARS population, Ferreira 2019) validation cohorts.

Results

Hierarchical clustering of the core profiles (Fig. 1a) revealed 8 clusters of pts in the discovery cohort displaying toxicity rates ranging from 0 to 60% (Fig. 1b). The cluster with the highest rate (10 pts, 7% cohort, 38% toxicity population) was significantly enriched for toxicity (Fisher’s exact test P<0.005). The high-risk MB composition was translated in the decision tree (Fig. 2 top), which can assess the MB-related risk of a patient to develop toxicity. We validated the model using the internal validation cohort and the external MARS early cohort (Fig. 2 bottom). A higher rate of toxicity is observed in all cohorts for pts with high-risk MB.


Conclusion

We highlighted that the predisposition to GI toxicity requires an understanding of the gut MB both at the ecological and at the functional level. Our analysis suggests that an altered ion homeostasis at the level of bacterial communities might predispose pts to the onset of GI toxicity. The predictive features identified are the relative abundance of genera Faecalibacterium, Bacteroides, Parabacteroides, Alistipes, Prevotella and Phascolarctobaterium and seem to generalize prediction beyond sequencing technology and platforms and overcome potential bias associated with the ethnic origin of patients (at least for what concern western European countries).
The study opens up concrete prospects for the use of baseline faecal samples in the clinical practice to improve pre-RT toxicity risk assessment and RT planning optimization.
MicroLearner was funded under the Call for the Promotion of Institutional Research INT-year 2016, 5 × 1000 Italian Ministry of Health. MicBioRadio was funded by FRRB, ID 2721017